SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-083600
Filing Date
2020-07-15
Accepted
2020-07-15 08:15:10
Documents
7
Period of Report
2020-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2024672-1_8k.htm 8-K 28659
2 EXHIBIT 4.1 tm2024672d1_ex4-1.htm EX-4.1 106225
3 EXHIBIT 4.2 tm2024672d1_ex4-2.htm EX-4.2 111470
4 EXHIBIT 4.3 tm2024672d1_ex4-3.htm EX-4.3 91765
5 EXHIBIT 10.1 tm2024672d1_ex10-1.htm EX-10.1 141311
6 EXHIBIT 99.1 tm2024672d1_ex99-1.htm EX-99.1 13169
7 GRAPHIC tm2024672d1_ex99-1img01.jpg GRAPHIC 3971
  Complete submission text file 0001104659-20-083600.txt   499570
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 201028290
SIC: 2836 Biological Products, (No Diagnostic Substances)